SGRY vs THC
SGRY: Surgery Partners owns and operates a national network of over 200 ambulatory surgery centers, surgical hospitals, and physician practices focused on delivering cost-effective outpatient surgical care. THC: A nationwide hospital and ambulatory surgery network with deep expertise in acute, specialty, and emergency care, backed by value-based care and revenue cycle management services.
Side-by-side fundamentals
| Metric | SGRY | THC | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $15.15 | $195.35 | |
| Market cap as of 2026-07-23 | $2.0B | $16.9B | |
| P/E as of 2026-07-23 | n/a | 9.94 | |
| PEG as of 2026-07-23 | 0.20 | 0.38 | SGRY lower |
| Net margin as of 2026-07-23 | -2.2% | +7.8% | THC higher |
| Gross margin as of 2026-07-23 | +25.2% | +82.5% | THC higher |
| Operating margin as of 2026-07-23 | +11.4% | +17.6% | THC higher |
| ROE as of 2026-07-23 | -4.6% | +40.6% | THC higher |
| ROA as of 2026-07-23 | -1.0% | +5.7% | THC higher |
| Debt / equity as of 2026-07-23 | 2.20 | 2.74 | SGRY lower |
| Revenue growth (YoY) as of 2026-07-23 | -20.5% | +6.6% | THC higher |
| Revenue CAGR (3y) SEC XBRL | +59.1% | +3.6% | SGRY higher |
| Beta as of 2026-07-23 | 1.95 | 1.27 | |
| 1-year return as of 2026-07-22 close | -31.3% | +25.2% | THC higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.